Your browser doesn't support javascript.
loading
Botulinum toxin for the management of spasticity in multiple sclerosis: the Italian botulinum toxin network study.
Moccia, Marcello; Frau, Jessica; Carotenuto, Antonio; Butera, Calogera; Coghe, Giancarlo; Barbero, Pierangelo; Frontoni, Marco; Groppo, Elisabetta; Giovannelli, Morena; Del Carro, Ubaldo; Inglese, Cristina; Frasson, Emma; Castagna, Anna; Buccafusca, Maria; Latino, Pamela; Nascimbene, Caterina; Romano, Marcello; Liotti, Vitalma; Lanfranchi, Stefania; Rapisarda, Laura; Lori, Silvia; Esposito, Marcello; Maggi, Loredana; Petracca, Martina; Lo Fermo, Salvatore; Altavista, Maria Concetta; Bono, Francesco; Eleopra, Roberto; Brescia Morra, Vincenzo.
Afiliación
  • Moccia M; Multiple Sclerosis Clinical Care and Research Centre, Department of Neuroscience, Reproductive Sciences and Odontostomatology, "Federico II" University of Naples, Via Sergio Pansini 5, edificio 17 piano terra, 80131, Naples, Italy. moccia.marcello@gmail.com.
  • Frau J; Queen Square MS Centre, UCL Queen Square Institute of Neurology, University College London, London, UK. moccia.marcello@gmail.com.
  • Carotenuto A; Multiple Sclerosis Centre, Department of Medical Science and Public Health, University of Cagliari, ATS Sardegna, Cagliari, Italy.
  • Butera C; Multiple Sclerosis Clinical Care and Research Centre, Department of Neuroscience, Reproductive Sciences and Odontostomatology, "Federico II" University of Naples, Via Sergio Pansini 5, edificio 17 piano terra, 80131, Naples, Italy.
  • Coghe G; Department of Neurology, Institute of Experimental Neurology, Scientific Institute "San Raffaele", Milan, Italy.
  • Barbero P; Multiple Sclerosis Centre, Department of Medical Science and Public Health, University of Cagliari, ATS Sardegna, Cagliari, Italy.
  • Frontoni M; Neurology Unit, "San Luigi Gonzaga" Hospital, Orbassano, Italy.
  • Groppo E; Neurology Unit, "Ordine Mauriziano di Torino" Hospital, Turin, Italy.
  • Giovannelli M; Department of Human Neuroscience, "La Sapienza" University, Rome, Italy.
  • Del Carro U; IRCCS Fondazione Don Carlo Gnocchi, Milan, Italy.
  • Inglese C; "Sant'Andrea" University Hospital, Rome, Italy.
  • Frasson E; Department of Neurology, Institute of Experimental Neurology, Scientific Institute "San Raffaele", Milan, Italy.
  • Castagna A; Multiple Sclerosis Centre, Department of Medical Science and Public Health, University of Cagliari, ATS Sardegna, Cagliari, Italy.
  • Buccafusca M; Neurology Unit, Cittadella Hospital, Cittadella, Italy.
  • Latino P; IRCCS Fondazione Don Carlo Gnocchi, Milan, Italy.
  • Nascimbene C; Multiple Sclerosis Centre, Neurology and Neuromuscular Unit, "G. Martino" University Hospital, Messina, Italy.
  • Romano M; "Sant'Andrea" University Hospital, Rome, Italy.
  • Liotti V; "Luigi Sacco" Hospital, Department of Neurology, University of Milan, Milan, Italy.
  • Lanfranchi S; "Villa Sofia-Cervello" Hospital, Palermo, Italy.
  • Rapisarda L; Physical Medicine and Rehabilitation Unit, Popoli Hospital, Pescara, Italy.
  • Lori S; Neurology Unit, "Valle Olona" Hospital, Gallarate, Italy.
  • Esposito M; Centre for Botulinum Toxin Therapy, Institute of Neurology, "Magna Graecia" University, Catanzaro, Italy.
  • Maggi L; Regional Referral Centre for Chemical Denervation, Neurophysiology Unit, Department of Neuro-musculoskeletal and Sensory Organs, Careggi Hospital, Florence, Italy.
  • Petracca M; Department of Neuroscience, Reproductive Sciences and Odontostomatology, "Federico II" University, Naples, Italy.
  • Lo Fermo S; Rehabilitation and Physical Medicine Unit, Department of Aging, Neurological, Orthopaedic Science, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Altavista MC; Movement Disorder Unit, Teaching Hospital 'Fondazione Policlinico Universitario A. Gemelli IRCSS', Rome, Italy.
  • Bono F; Institute of Neurology, Catholic University of Sacred Heart, Rome, Italy.
  • Eleopra R; Multiple Sclerosis Centre, A.O.U. Policlinico "Vittorio Emanuele", Catania, Italy.
  • Brescia Morra V; Neurology Unit, "San Filippo Neri" Hospital, Rome, Italy.
Neurol Sci ; 41(10): 2781-2792, 2020 Oct.
Article en En | MEDLINE | ID: mdl-32281038
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Toxinas Botulínicas Tipo A / Esclerosis Múltiple / Fármacos Neuromusculares Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Adult / Female / Humans / Middle aged País/Región como asunto: Europa Idioma: En Revista: Neurol Sci Asunto de la revista: NEUROLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Toxinas Botulínicas Tipo A / Esclerosis Múltiple / Fármacos Neuromusculares Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Adult / Female / Humans / Middle aged País/Región como asunto: Europa Idioma: En Revista: Neurol Sci Asunto de la revista: NEUROLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Italia